Mitoxantrone Completed Phase 3 Trials for Prostatic Neoplasms Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00436839Taxotere Prostate Cancer New Indication Registration Trial in China